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Abstract
Microvascular leakage due to endothelial barrier dysfunction is a prominent feature of T
helper 2 (Th2) cytokine mediated allergic inflammation. Interleukin-4 (IL-4) is a potent Th2
cytokine, known to impair the barrier function of endothelial cells. However, the effectors
mediating IL-4 induced cytoskeleton remodeling and consequent endothelial barrier dys-
function remain poorly defined. Here we have used whole genome transcriptome profiling
and gene ontology analyses to identify the genes and processes regulated by IL-4 signaling
in human coronary artery endothelial cells (HCAEC). The study revealed Wnt5A as an
effector that can mediate actin cytoskeleton remodeling in IL-4 activated HCAEC through
the regulation of LIM kinase (LIMK) and Cofilin (CFL). Following IL-4 treatment, LIMK and
CFL were phosphorylated, thereby indicating the possibility of actin stress fiber formation.
Imaging of actin showed the formation of stress fibers in IL-4 treated live HCAEC. Stress
fiber formation was notably decreased in the presence of Wnt inhibitory factor 1 (WIF1).
Non-invasive impedance measurements demonstrated that IL-4 increased the permeability
and impaired the barrier function of HCAECmonolayers. Silencing Wnt5A significantly
reduced permeability and improved the barrier function of HCAECmonolayers upon IL-4
treatment. Our study identifies Wnt5A as a novel marker of IL-4 activated vascular endothe-
lium and demonstrates a critical role for Wnt5A in mediating IL-4 induced endothelial barrier
dysfunction. Wnt5A could be a potential therapeutic target for reducing microvascular leak-
age and edema formation in Th2 driven inflammatory diseases.
Introduction
Interleukin-4 (IL-4) is a multifunctional pleiotropic type I cytokine secreted by activated T
helper (Th) 2 cells, basophils, eosinophils and mast cells [1, 2]. Functionally, IL-4 induces the
differentiation of antigen stimulated naïve T cells to a Th2 phenotype [3, 4]. It also regulates
immunoglobulin (Ig) class switching so that B lymphocytes express IgE [5], and regulates apo-
ptosis, cell proliferation and expression of several genes in different cell types such as fibro-
blasts, macrophages, endothelial and epithelial cells [1, 2]. IL-4 drives the ‘alternative
activation of macrophages’ to produce the M2 phenotype, which is crucially involved in type 2
immunity. Thus, through its effects on multiple cell types and by binding to alternative cell
PLOSONE | DOI:10.1371/journal.pone.0156002 May 23, 2016 1 / 22
a11111
OPEN ACCESS
Citation: Skaria T, Burgener J, Bachli E, Schoedon G
(2016) IL-4 Causes Hyperpermeability of Vascular
Endothelial Cells through Wnt5A Signaling. PLoS
ONE 11(5): e0156002. doi:10.1371/journal.
pone.0156002
Editor: Binu Tharakan, Texas A&M University Health
Science Center College of Medicine & Baylor Scott
and White Health, UNITED STATES
Received: September 15, 2015
Accepted: May 6, 2016
Published: May 23, 2016
Copyright: © 2016 Skaria et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All microarray data
files for the IL-4 regulated transcriptome in HCAEC
are available from the NCBI GEO database
(accession number GSE64860).
Funding: GS received the following grants for this
study: 1. Swiss National Science Foundation (No. 31-
124861; http://www.snf.ch/en/Pages/default.aspx); 2.
Novartis Stiftung für Biologisch-Medizinische
Forschung (No. 12B35; http://www.stiftungmedbiol.
novartis.com/). The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
surface receptors [1], IL-4 plays critical roles in allergic inflammation [6], immune response to
extracellular parasites including helminths, autoimmunity [2] and tumor inflammation and
metastasis [1, 7].
Recent evidence suggests a potential role for IL-4 in generating a proinflammatory environ-
ment in vascular endothelial cells (VEC) [8]. VEC are essential for maintaining vascular
homeostasis in normal physiological conditions [9]. Under pathophysiological conditions, acti-
vated blood components, pathogens or inflammatory mediators such as cytokines act upon
VEC and heavily alter their functions, conferring on them an inflamed phenotype. These alter-
ations include a change from the anticoagulant phenotype to a procoagulant state, increased
production of vasoactive substances, expression of cell adhesion molecules, synthesis of inflam-
matory mediators including chemoattractants, and endothelial barrier dysfunction causing
microvascular leakage. It has been demonstrated that IL-4 upregulates the expression of vascu-
lar cell adhesion molecule (VCAM)-1 [10–12], IL-6 [12–14] and monocyte chemotactic pro-
tein (MCP) [12, 14] in human umbilical vein endothelial cells (HUVEC). Moreover,
stimulation with IL-4 increased the adhesion of peripheral blood monocytes [15] and T cells
[16] to HUVEC. IL-4 has been shown to induce cytoskeletal rearrangements in HUVEC and
significantly regulate their proliferation [17]. Further, IL-4 acts as a modest mitogen for both
macro and microvascular endothelial cells [8, 17–19]. IL-4 has proatherogenic effects and
induces the apoptosis of endothelial cells causing increased endothelial cell turnover [20]. It
has been demonstrated that IL-4 induces hyperpermeability of HUVEC, causing vascular leak-
age [21], however, effectors responsible for IL-4 induced endothelial hyperpermeability and
consequent barrier dysfunction remain unidentified. Moreover, these previous studies address-
ing the effects of IL-4 on endothelial inflammation used HUVEC as the primary endothelial
cell model system. HUVEC that are obtained from the immune naïve foetal tissue shows signif-
icant variations in function compared with adult vascular endothelium and hence may be an
inappropriate primary cell model of vascular endothelium [22]. The targets and effects of IL-4
signaling in adult VEC, therefore, may vary from HUVEC and have to be elucidated.
In the present study, we used transcriptome profiling to identify the genes regulated by
paracrine IL-4 signaling in our established in vitromodel of adult VEC, cultured human coro-
nary artery endothelial cells (HCAEC) [23]. Here we identify Wnt5A as one of the genes signif-
icantly upregulated by IL-4 treatment. We further demonstrate a critical role for IL-4 induced
Wnt5A in impairing barrier function of endothelial monolayers. Our findings suggest a promi-
nent role for Wnt5A in causing microvascular leakage associated with IL-4 driven allergic
inflammation and other pathophysiological conditions.
Materials and Methods
Cell Culture
HCAEC and human pulmonary artery endothelial cells (HPAEC) purchased from Clonetics
(Lonza, USA) were cultured in EBM-2 medium (Clonetics, Lonza, USA) supplemented with
EGM-2MV Single Quots and 5% FBS (Clonetics, Lonza) as described previously [23]. For
experiments, cells at passages three to six were used and the serum in culture medium was
decreased to 2% FBS. Macrophages derived from human PBMC were cultured as described
[24]. Cells were cultured under standard conditions (37°C, 5% CO2, 80% humidity) in a Class
100 HEPA air filtered system (SteriCult, Fisher Scientific, Switzerland). Culture medium with-
out antibiotics was used to prevent masked low-level contamination in cell cultures. Treat-
ments were carried out using recombinant human (rh) IL-4 (4 ng/mL; purity>98%;
PeproTech, USA), rh IL-6 (20 U/mL; purity>98%; PeproTech, USA), rh soluble Frizzled-
related peptide-1 (sFRP1; 10 μg/mL; purity> 95%; R&D systems, USA), rh/mouse Wnt5A
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(250 ng/mL; CHO-derived Gln38-Lys380, purity>80%, endotoxin level<1.0 EU/μg of pro-
tein; R&D systems, USA) and rh Wnt inhibitory factor 1 (WIF1; 15 μg/mL; purity>97%; R&D
systems, USA). Sterile biopure ep Dualfilter T.I.P.S. sterile filter tips (Eppendorf, Germany)
were used throughout the study.
RNA Isolation and Quantitative Real-Time PCR (qRT-PCR) Analyses
RNA isolation and qRT-PCR using the HPRT gene as endogenous control were performed as
described previously [25]. Sequence specific PCR detection primers used for Wnt5A, IL-6 and
HPRT are as follows: Wnt5A forward, 5'-AGT TGC CTA CCC TAG C-3'; Wnt5A reverse, 5'-
GTG CCT TCG TGC CTA T-3'; IL-6 forward, 5'-CCT GAC CCA ACC ACA AA-3'; IL-6
reverse, 5'-AGT GTC CTA ACG CTC ATA C-3'; HPRT forward, 5'-CCA GTC AAC AGG
GGA CAT AAA-3'; HPRT reverse, 5'-CAC AAT CAA GAC ATT CTT TCC AGT-3'. Thermal
cycling conditions set in the 7500 Fast Real-Time PCR System (Applied Biosystems, USA)
involved an initial denaturation step (10 min, 95°C) followed by 40 cycles of denaturation (15
sec, 95°C), annealing (30 sec, 55°C), and extension (30 sec, 72°C).
Differential Gene Expression Profiling
Microarray based gene expression profiling and scanning, feature extraction and data normali-
zation of microarrays were performed as described previously [25]. Complete data sets for the
IL-4 regulated transcriptome in HCAEC are available in the NCBI GEO data repository, acces-
sion number GSE64860.
Microarray Data Analyses
The preprocessed microarray data was analyzed using GeneSpring GX 9.0 Software (Agilent
Tech. Inc.) with default settings for two color arrays and a fold change (FC) cutoff of 2. Using
MetaCore™ GeneGO software (Thomson Reuters, http://portal.genego.com), genes regulated
2 fold in their expression and satisfying a P value<0.05 were grouped into pathways accord-
ing to their biologic functions and gene ontology (GO) classes.
Immunofluorescence Staining
HCAEC were grown in four-chamber culture slides coated with rat tail collagen type I (diluted
0.01% in sterile pyrogen-free water; BD Biosciences, USA). To stain for VE-cadherin, HCAEC
were grown to a confluent monolayer. After treatment with appropriate stimuli, cells were
fixed with 4% formalin in PBS for 20 min. After washing three times with PBS (pH 7.4) at
room temperature (RT), slides were treated with blocking solution for 1 h at RT. Depending on
the source of secondary antibodies, blocking solution containing either 10% goat serum and
1% BSA (for secondary antibodies derived from goat) or 10% rabbit serum and 1% BSA in PBS
(for secondary antibodies derived from rabbit) was used. After washing three times with PBS at
RT, slides were incubated with primary antibodies diluted in blocking solution at 4°C over-
night. The following antibodies were used with dilutions indicated: rabbit anti-VE-cadherin,
polyclonal (1:100; Product No. 2158, Cell Signaling Technology), rabbit anti-phospho LIMK2,
polyclonal (pT505; 1:300; Product No. Ab131343, Abcam), rabbit anti-phospho CFL, poly-
clonal (pS3; 1:500; Product No. Ab100836, Abcam), goat anti-Wnt5A, polyclonal (1:500; Cat.
No. AF645, R&D Systems). Slides were then washed three times with PBS at RT. Depending on
the first antibody’s species, slides were incubated with Alexa 568 labelled goat anti-rabbit or
rabbit anti-goat secondary antibodies (1:2000; Molecular Probes, Invitrogen, USA) for 1 h at
RT in the dark. Incubations with secondary antibody were combined with Alexa Fluor 488
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Phalloidin (1:80; Molecular Probes, Invitrogen, USA) to visualize F-actin. Slides were washed
three times with PBS at RT, counterstained with 10 μg/mL diamidino-phenylindole (DAPI;
Sigma-Aldrich) and mounted using ProLong1Gold Antifade (Life Technologies, USA). Images
were captured using an Axioskope microscope equipped with an AxioCamMRm digital camera
and the associated AxioVision Rel.4.6 software (Carl Zeiss, Feldbach Switzerland). Cellular fluo-
rescent intensity was quantified from five different areas of the respective fluorescent images
using ImageJ based Fiji software (Fiji is just ImageJ) and corrected for background fluorescence.
Immunoblotting
Immunoblotting was performed as described previously with some modifications [26]. Equal
amounts of protein were resolved on Criterion Stain-Free Precast Gels (Cat. 567–8074, Bio-
Rad) and transferred onto PVDF membranes. After incubating with blocking solution (5%
BSA in TBS containing 0.1% Tween-20), membranes were probed with primary antibodies
diluted in blocking solution at 4°C overnight. The following antibodies were used with dilu-
tions indicated: rabbit anti-phospho LIMK2, polyclonal (1:500; Product No. Ab131341,
Abcam), rabbit anti-LIMK2, polyclonal (1:1000; Product No. PA5-36062, ThermoFischer Sci-
entific), rabbit anti-phospho CFL, polyclonal (1:1000; Product No. Ab100836, Abcam), rabbit
anti- CFL, polyclonal (1:1000; Product No. Ab42824, Abcam), goat anti-Wnt5A, polyclonal
(1:200; Cat. No. AF645, R&D Systems). Blots were then washed, incubated with anti-rabbit
IgG- HRP-linked whole antibody (1:5000; Cat. No. NA934V, GE Healthcare UK Limited) or
anti-goat IgG-HRP (1:2000; Cat. No. P0160, Dako Cytomation) for 1 h at RT and visualized
with ECL Plus Western blotting detection reagents (Amersham Bioscience) in a ChemiDoc
MP imaging system (Bio-Rad). Blots were analyzed by densitometry using Bio-Rad Image lab
5.2.1 software. For quantification of phosphoproteins, ratios of pLIMK2/LIMK2, and pCFL/
CFL were calculated. In-gel stained total protein served as loading control for Wnt5A protein
quantification. Data are expressed as mean ± SEM from three independent experiments.
Inhibition of Rho associated protein serine/threonine kinases (ROCK)
Y-27632 (Calbiochem; Millipore, USA) at a concentration of 10 μM [27] was used to inhibit
the activation of ROCK. ROCK inhibition experiments were performed by incubating cells in
medium containing Y-27632 alone or in combination with IL-4 for 1 h and 4 h.
Live Cell Imaging of Actin
HCAEC monolayers were grown in rat tail collagen type I coated optical 96 microwell culture
plates (Thermo Scientific, USA). Cells were incubated with CellLight1 Actin-RFP probe (Cat.
No. C10583, Life Technologies, USA) for 16 h (time needed for probe transfection/incorpo-
ration) according to manufacturer’s instructions. After medium change, cells in triplicate wells
were treated with IL-4 orWnt5A alone or in combination with sFRP1 orWIF1. Cells were fur-
ther incubated up to 24 h. At the time indicated, images of live actin cytoskeleton organization
were obtained using the Axio Observer.Z1 inverted microscope equipped with an AxioCam
MRm digital camera and the associated ZEN 2012 software (Carl Zeiss, Feldbach, Switzerland).
Wnt5A Silencing
To knockdownWnt5A expression, HCAEC grown up to 80% confluency in 24-well plates
were incubated with transfection complexes formed fromWnt5A-siRNA (5 nM;
Hs_Wnt5A_6, Cat. No. SI03025596; Qiagen) and 6 μL/mL HiPerFect Transfection reagent
(Qiagen GmbH, Hilden, Germany) in EBM-2 basal medium (Clonetics, Lonza, USA) for 24 h.
IL-4 and Endothelial Barrier Function
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After splitting using Trypsin EDTA, transfected cells were seeded onto collagen coated 6 well
plates, retransfected for an additional round as above and incubated until the cells reached 90%
confluency. HCAEC were also transfected with validated AllStars negative control siRNA (Qia-
gen) in parallel to control for ‘off target’ effects of siRNAs. Cells were then either treated with
IL-4 for 8 h and lysed (for qRT-PCR analyses) or trypsinized and seeded into collagen-coated
8W10E+ arrays (for barrier function assays, see below). Treatments were carried out in EGM-2
MVmedium with 2% FBS devoid of transfection complexes. To immunostain for Wnt5A,
HCAEC transfected once with Wnt5A-siRNA were harvested by trypsinization and seeded
into collagen-coated BD Falcon 4 chamber culture slides (BD Biosciences, USA). There, an
additional round of Wnt5A-siRNA transfection was performed as in 24-well plates, incubated
until the cells attained monolayer confluency and fixed for immunostaining.
Electric Cell-substrate Impedance Sensing (ECIS) of Endothelial Barrier
Function
Using ECIS, the response of endothelial barrier to the stimulus can be assessed by continuously
recording changes in transendothelial resistance (TEER) [28, 29]. Endothelial barrier function
was detected in real time using the ECIS1 Z-theta system (Applied Biophysics, http://www.
biophysics.com/barrierfunction.php) with associated software v.1.2.126 PC as follows: after
equilibrating with EBM-2 basal medium (Clonetics, Lonza, USA) for 24 h, 8W10E+ arrays
were coated with rat tail collagen type I (diluted 0.01% in sterile pyrogen-free water; BD
Biosciences, USA) for 12 h. A monodisperse suspension of HCAEC in EGM-2 MVmedium
(Clonetics, Lonza, USA) supplemented with 5% FBS was added to the arrays at a density of
80,000–90,000 cells/well and incubated up to 24 h to form a uniform dense monolayer (S1 Fig).
Treatments were carried out in fresh medium with or without stimuli. Resistance of HCAEC
monolayers was continuously measured (every 5 min) in Ohms at multiple frequencies ranging
from 62.6 Hz to 64 kHz. Each of the eight wells of the 8W10E+ arrays contain 40 electrodes
that trace the cells at 40 different locations in each well. The measurements of duplicate wells
were grouped and averaged to plot as a single curve with error bars representing mean ± SD.
Automated Cell Migration Assay Using ECIS
The non-invasive ECIS assisted wound healing assay makes a highly reproducible wound with
a specific diameter of 250 μmwithout damaging cells in the surrounding region in 8W1E
arrays [30]. It was used for studying cell migration and was performed as follows: equilibration
and collagen coating of 8W1E single electrode arrays were performed as described above for
8W10E+ arrays. A monodisperse suspension of HCAEC in EGM-2 MVmedium (Clonetics,
Lonza, USA) supplemented with 5% FBS was added to the arrays at a density of 80,000–90,000
cells/well and incubated up to 24 h to form a uniform dense monolayer. Treatments were car-
ried out as described above for barrier function assays. Three hours after treatment, wounding
was activated with default conditions for 8W1E arrays (1400 μA, 60000 Hz for 20 sec). This
killed the treated cells adhering to the electrode surface in 8W1E slides to create a wound. After
wounding, impedance was continuously recorded to observe the migration of cells to the
wounded area to form a confluent HCAEC monolayer.
Statistical Analysis
Data were analyzed using GraphPad Prism software version 5.04 (GraphPad Software, San
Diego, CA). An unpaired 2-tailed Student’s t-test or for comparison of data among groups,
1-way ANOVA followed by the Newman-Keuls test was used and differences were considered
statistically significant at P<0.05.
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Results
Gene expression changes in IL-4 treated adult human VEC
To identify all genes regulated by IL-4 treatment in HCAEC, we performed dual channel oligo-
nucleotide based transcriptome profiling. The transcriptome profile of HCAEC treated with
IL-4 for 8 h was compared to that of non-treated cells using whole human genome oligomi-
croarrays. The preprocessed gene expression data was analyzed by GeneSpring software to
identify the genes in treated cells that showed a minimum two fold change in expression com-
pared with non-treated cells. IL-4 regulated 2747 genes, of which 1395 genes were upregulated
and 1352 genes were down regulated. PMCH,HAS3, CCL26, OTOGL, TMTC1, CH25H,
VCAM1, DKK2, SLC10A7,MASP1, COL3A1 andWNT5A were the genes most upregulated by
IL-4. The top one hundred genes upregulated by IL-4 in HCAEC are listed in S1 Table.
LRRC14B, DNAH2, TMEM191B, FAM47B, GPR116, TTC9, NOG, OR13C8, GPRC6A, CSN3,
TMEM236 and PRKG2 were the genes most downregulated by IL-4. The top one hundred
genes downregulated by IL-4 in HCAEC are listed in S2 Table.
All differentially regulated genes contained in the preprocessed microarray data were sub-
jected to GO analyses using MetaCore™ GeneGO software. Using this tool, genes regulated at
least two fold in their expression were clustered on the basis of their function to generate statis-
tically significant cellular pathways. Among the top twenty five biological pathways regulated
by IL-4, six were associated with immune responses (Fig 1A and 1B). The ‘Immune respon-
se_Oncostatin M signaling via JAK-Stat in human cells’ is the pathway most significantly regu-
lated by IL-4 treatment in HCAEC (Fig 1A). Genes of this pathway regulated by IL-4 (e.g.
CCL2, IL6ST,MMP1 and VEGFA; Table 1) are mainly associated with immune responses
involving monocyte-endothelial interactions and endothelial permeabilization. The ‘Develop-
ment_Regulation of epithelial-to-mesenchymal transition (EMT)’ is the second most signifi-
cant biological process for IL-4 in HCAEC (Fig 1A). Among the genes of this pathway
regulated by IL-4 (Table 1), DLL4 and PDGFB are involved in cell proliferation and migration,
SNAI1 and ZEB1 are involved in promoting the transition of cells from epithelial to mesenchy-
mal state, SNAI2 is involved in repressing the expression of cellular junctional proteins and
Wnt5A is involved in cell migration and inflammation.
The ‘Cytoskeleton remodeling_TGF, Wnt and cytoskeletal remodeling’ pathway is the third
most significant biological process for IL-4 in HCAEC (Fig 1A). Among the genes regulated in
this pathway areWnt5A,Wnt1, VEGFA, LIMK2 and CFL1 (Table 1). The MetaCore™map of
this pathway showing these genes within their signaling context indicates that IL-4 upregulates
Wnt as most significant ligand for the cytoskeleton remodeling (Fig 2, upper right quarter),
and causes downstream regulation of LIMK2 and CFL1 (Fig 2, lower left quarter). LIMK2 and
CFL1 are responsible for actin polymerization. Among the other genes of this pathway are
KDR and FZDs (Fig 2, Table 1), which are involved in VEGF and Wnt signaling.
Data from our study confirm previous findings that IL-4 upregulatesVCAM-1 [10–12], IL-6
[12–14], MCP [12, 14] and LIFR [12] in VEC (S1 Table). Thus, it corroborates the proposed
role of IL-4 as an ‘alternative inflammatory’ cytokine. With respect to transcription factors
mediating IL-4 induced gene expression in VEC, the present study demonstrates that IL-4
upregulates the expression of genes encoding FOSB (a member of the activator protein-1 fam-
ily), GATA3 and EGR1 (S3 Table).
Confirmation of Wnt5A expression
Since Wnt5A was previously identified as an inflammatory mediator, and expression of the
gene is shown to be significantly upregulated by IL-4 in microarray analysis, we measured
IL-4 and Endothelial Barrier Function
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Wnt5A mRNA levels in HCAEC treated with IL-4 for 8 h using qRT-PCR. Consistent with the
microarray data, IL-4 significantly upregulated Wnt5A mRNA levels (Fig 3A). The induction
of IL-6 mRNA was considered as indication of positive IL-4 stimulation of HCAEC (Fig 3B).
To confirm that IL-4 induced Wnt5A expression is not only specific for HCAEC but also for
endothelial cells from different vascular beds, we measured Wnt5A mRNA level in IL-4 treated
HPAEC. Consistent with findings obtained in HCAEC, 8 h treatment with IL-4 significantly
upregulated Wnt5A in HPAEC (Fig 3A). We further confirmedWnt5A induction at the pro-
tein level by immunofluorescence staining and immunoblot. In accordance with qRT-PCR and
microarray data, treatment with IL-4 notably increased the levels of Wnt5A protein in HCAEC
(Fig 3C–3E).
LIM kinase (LIMK) 2 and Cofilin-1 (CFL1) are phosphorylated in IL-4
treated HCAEC
GO analysis of gene expression data shows that IL-4 regulated the LIMK2 and CFL1 genes,
which are involved in cytoskeleton remodeling (Fig 2, Table 1). LIMK2, a serine/threonine/
tyrosine kinase, is a downstream target of ROCK. When phosphorylated by the activated
ROCK, LIMK2 phosphorylates the actin depolymerization factor CFL1 [31–33]. Therefore, we
investigated whether LIMK2 and CFL1 proteins are phosphorylated following IL-4 treatment
in HCAEC. Immunofluorescence staining and immunoblot employing specific antibodies
were used to detect and quantify the phosphorylated forms of LIMK2 (pLIMK2) and CFL1
Fig 1. The twenty five biological pathways most significantly (P<0.05) regulated by IL-4 treatment in HCAEC. (A, B) Pathways represented as
histograms are ranked by the–log value (P value). Length of histogram corresponds to the number of genes associated with that specific pathway.
doi:10.1371/journal.pone.0156002.g001
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(pCFL1). Compared to non-treated cells, pLIMK2 and pCFL1 levels were markedly increased
in HCAEC treated with IL-4 for 1 h and 4 h respectively (Fig 4A–4D). At earlier (30 min, 2 h)
or later (8 h) time points, no significant change in phosphorylation of LIMK2 and CFL1,
respectively, was observed (data not shown). Combining IL-4 with the ROCK inhibitor Y-
27632 significantly suppressed the phosphorylation of LIMK2 and CFL1 compared with IL-4
alone (Fig 4A–4D).
IL-4 induced stress fiber formation can be decreased byWnt antagonist
Since inactivation of CFL1 by phosphorylation prevents actin depolymerization resulting in F-
actin stress fiber formation [32–34], and IL-4 treatment induced its phosphorylation, we next
investigated whether IL-4 causes stress fiber formation. Alterations in actin organization and
stress fiber formation were visualized by imaging actin-RFP in IL-4 treated live HCAEC.
Actin-RFP showed only a few thin stress fibers in non-treated HCAEC whereas formation of
thick actin stress fibers were visible in IL-4 treated cells (Fig 5).
Table 1. Key genes regulated by IL-4 in ‘Immune response_Oncostatin M signaling via JAK-Stat in human cells’, ‘Development_Regulation of epi-
thelial-to-mesenchymal transition (EMT)’ and ‘Cytoskeleton remodeling_TGF,Wnt and cytoskeletal remodeling’ pathways in HCAEC.
Gene Symbol Accession Sequence Description Regulation
CAV1c NM_001172895 Homo sapiens caveolin 1 Down
CCL2a NM_002982 Homo sapiens chemokine (C-C motif) ligand 2 Up
CFL1c NM_005507 Homo sapiens coﬁlin 1 Down
CCND1a,c NM_053056 Homo sapiens cyclin D1 Down
DLL4b NM_019074 Homo sapiens delta-like 4 Down
FZD4b,c NM_012193 Homo sapiens frizzled class receptor 4 Up
FZD8b,c NM_031866 Homo sapiens frizzled class receptor 8 Up
FOXO3c NM_001455 Homo sapiens forkhead box O3 Up
HEY1b NM_001040708 Homo sapiens hes-related family bHLH transcription factor with YRPW motif 1 Down
IL6STa NM_001190981 Homo sapiens interleukin 6 signal transducer Up
JAG1b NM_000214 Homo sapiens jagged 1 Up
KDRc NM_002253 Homo sapiens kinase insert domain receptor Down
LIFRαa NM_002310 Homo sapiens leukemia inhibitory factor receptor alpha Up
LIMK2c NM_001031801 Homo sapiens LIM domain kinase 2 Down
MAPK13c NM_002754 Homo sapiens mitogen-activated protein kinase 13 Down
MAP2K3c NM_002756 Homo sapiens mitogen-activated protein kinase kinase 3 Down
MMP1a NM_002421 Homo sapiens matrix metallopeptidase 1 Up
MMP7c NM_002423 Homo sapiens matrix metallopeptidase 7 Up
MYLKc NM_053025 Homo sapiens myosin light chain kinase Down
MYLK2c NM_033118 Homo sapiens myosin light chain kinase 2 Down
PDGFβb NM_002608 Homo sapiens platelet-derived growth factor beta polypeptide Down
SNAI1b NM_005985 Homo sapiens snail homolog 1 Down
SNAI2b NM_003068 Homo sapiens snail homolog 2 Down
TGFβ2b NM_003238 Homo sapiens transforming growth factor, beta 2 Up
TGFβ3b NM_003239 Homo sapiens transforming growth factor, beta 3 Up
VEGFAa,c NM_001025366 Homo sapiens vascular endothelial growth factor A Up
WNT5Ab,c NM_003392 Homo sapiens wingless-type MMTV integration site family, member 5A Up
ZEB1b NM_001128128 Homo sapiens zinc ﬁnger E-box binding homeobox 1 Down
aGenes regulated by IL-4 in ‘Immune response_Oncostatin M signaling via JAK-Stat in human cells’ pathway.
bGenes regulated by IL-4 in ‘Development_Regulation of epithelial-to-mesenchymal transition (EMT)’ pathway.
cGenes regulated by IL-4 in ‘Cytoskeleton remodeling_TGF, Wnt and cytoskeletal remodeling’ pathway.
doi:10.1371/journal.pone.0156002.t001
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Functional clustering of the IL-4 regulated transcriptome showed upregulation of Wnt5A,
and this occurs upstream of LIMK2 and CFL1 regulation in the cytoskeleton remodeling
Fig 2. Metacore™map showing the signaling context of the genes contained in the ‘Cytoskeleton remodeling_TGF, Wnt and
cytoskeletal remodeling’ pathway.Genes regulated by IL-4 are marked by red and blue thermometer icons representing upregulated and
downregulated gene expression respectively.
doi:10.1371/journal.pone.0156002.g002
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Fig 3. Expression of Wnt5A in IL-4 treated HCAEC. Fold changes in the expression of (A) Wnt5A mRNA in 8 h IL-4
treated HCAEC and HPAEC and (B) IL-6 mRNA in 8 h IL-4 treated HCAEC. Data were obtained from three independent
qRT-PCR experiments run with duplicate samples and expressed as the mean ± SEM. *P<0.05. (C) Wnt5A protein
expression in non-treated and IL-4 treated HCAEC. Wnt5A is immunostained (red), nuclei (DAPI, blue). Photomicrographs
were acquired using a Zeiss Axioskope equipped with AxioCamMRm digital camera and AxioVision Rel.4.6 software.
Original magnification, 200×. (D) Mean cellular fluorescent intensity of Wnt5A. Data represent mean ± SD from five different
regions. *P<0.05. The experiment was repeated five times, with analogous results. (E) Immunoblot of Wnt5A induction in
IL-4 treated HCAEC. In-gel stained 50 kDa band, served as loading control and for densitometry normalization. Left band,
non-treated cells; right band, IL-4 treated cells. Data are mean ± SEM from three independent experiments. *P<0.05.
doi:10.1371/journal.pone.0156002.g003
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Fig 4. Phosphorylation of LIMK2 and CFL1 in IL-4 treated HCAEC. (A) pLIMK2 (pT505) and pCFL1 (pCofilin-1, pS3) were immunostained
(red) in HCAEC treated with IL-4 either alone or in combination with Y-27632. F-actin (fluorescent phalloidin, green) and nuclei (DAPI, blue)
were also stained. Photomicrographs were acquired using a Zeiss Axioskope equipped with AxioCamMRm digital camera and AxioVision
Rel.4.6 software. Original magnification, 200×. (B) Mean cellular fluorescent intensities of pLIMK2 and pCFL1. Data represent mean ± SD
from five different regions. *P<0.05. The experiment was repeated three times, with analogous results. (C, D) Immunoblots of pLIMK2,
LIMK2, pCFL and CFL in HCAEC treated with IL-4 either alone or in combination with Y-27632. Left band, non-treated cells; middle band, IL-
4 treated cells; right band, IL-4+Y-27632 treated cells. Data are mean ± SEM from three independent experiments. *P<0.05.
doi:10.1371/journal.pone.0156002.g004
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process (Fig 2). Having verified upregulated Wnt5A expression and increased stress fiber for-
mation through LIMK2 and CFL1 phosphorylation in IL-4 treated HCAEC, we next investi-
gated the role of Wnt5A in IL-4 induced stress fiber formation using Wnt antagonists. As
Frizzleds (Fzds) have long been considered the receptors for Wnts, and transcriptome profiling
in this study showed upregulation of some Fzd genes by IL-4 in HCAEC, we first attempted to
block Wnt5A/Fzd signaling using sFRP1. Treating HCAEC with IL-4 in the presence of sFRP1
did not influence actin stress fiber formation (Fig 5). As Ryk is described as an alternative
receptor for Wnts [35], we next tested whether inhibiting Wnt5A/Ryk interaction by using
WIF1 has an effect on IL-4 induced stress fiber formation. Stress fiber formation was notably
suppressed when HCAEC were treated with a combination of IL-4 and WIF1 (Fig 5). HCAEC
showed increased stress fiber formation uponWnt5A treatment, however this was notably sup-
pressed after treatment with a combination of Wnt5A andWIF1 (Fig 5).
IL-4 disrupts the assembly of VE-cadherin in inter-endothelial junctions
(IEJs)
Actin stress fiber formation leads to disassembly of VE-cadherin in IEJs and causes intercellu-
lar gap formation in endothelial monolayers [36]. Since IL-4 induced stress fiber formation, we
next investigated if IL-4 affected VE-cadherin assembly in HCAEC. Immunofluorescence
Fig 5. Stress fiber formation in IL-4 treated HCAEC. Live actin-RFP staining showing the formation of actin stress fibers in HCAEC treated with IL-4 or
Wnt5A in the absence or presence of sFRP1 andWIF1. Expression of de novo synthesized RFP-actin after transfection as outlined in methods was visually
observed up to 24 h. Photomicrographs of stress fiber formation were taken randomly at 12 h after stimulation with IL-4 andWnt5A alone or in the presence
of sFRP1 andWIF1 using Zeiss Axio Observer.Z1 equipped with AxioCamMRm digital camera and ZEN 2012 software. Original magnification, 400×.
Independent identical experiments in triplicates were repeated at least three times, with analogous results.
doi:10.1371/journal.pone.0156002.g005
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staining showed continuous distribution of VE-cadherin along the cellular periphery, and tight
intercellular contacts in non-treated HCAEC monolayers (Fig 6A). In contrast, IL-4 treated
HCAEC monolayers showed small inter-endothelial gaps with marked loss of VE-cadherin at
intercellular regions (Fig 6B).
IL-4 induced endothelial hyperpermeability is decreased by silencing
Wnt5A
Stress fiber formation and IEJ disruption accompanied by inter-endothelial gap formation
impairs barrier function and increases permeability of endothelial monolayers [36]. Since IL-4
upregulated Wnt5A, and inhibiting Wnt5A with WIF1 decreased IL-4 induced stress fiber for-
mation in HCAEC, we investigated whether Wnt5A mediated IL-4 induced endothelial hyper-
permeability. Alterations in TEER of tight HCAEC monolayers cultured in 8W10E+ slides
were recorded in real time by ECIS. Treatment with IL-4 significantly reduced the TEER of
HCAEC monolayers to alternating current (AC). Notably, IL-4 induced alterations in TEER
became apparent 3 h after treatment with IL-4 and persisted for more than 8 h (Fig 7A).
Fig 6. Assembly of VE-cadherin in IL-4 treated HCAEC. VE-cadherin immunostained (red) in HCAEC
either non-treated (A) or treated with IL- 4 for 8 h (B). Nuclei (DAPI, blue). Photomicrographs were acquired
using a Zeiss Axioskope equipped with AxioCamMRm digital camera and AxioVision Rel.4.6 software.
Original magnification, 400×.
doi:10.1371/journal.pone.0156002.g006
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Fig 7. ECIS barrier function assays showing the effect of Wnt5A in IL-4 induced hyperpermeability of
HCAEC.Uniform confluent monolayers of HCAEC cultured in stabilized and collagen coated ECIS 8W10E
+ arrays were treated with IL-4. TEER of HCAECmonolayers was measured in Ohms continuously every 5
min at multiple frequencies ranging from 62.6 Hz to 64 kHz, normalized to its value at time zero and plotted
with respect to time. Stimulations conducted in duplicate wells were grouped and averaged to plot a single
curve with error bars representing mean ± SD. Figures shown depict the resistance measurements
conducted at 4000 Hz and represent four independent experiments. (A) 1, non-treatedWnt5A-siRNA
transfected HCAEC; 2, non-treated non-transfected HCAEC; 3, IL-4 treatedWnt5A-siRNA transfected
HCAEC; 4, IL-4 treated non-transfected HCAEC. (B) 1, non-treated negative control siRNA transfected
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Next, we tested whether silencing Wnt5A improves the barrier function of IL-4 treated
HCAEC monolayers. HCAEC were transfected with siRNA against Wnt5A. qRT-PCR showed
that Wnt5A mRNA expression was approximately 60% lower in Wnt5A-siRNA transfected
cells than in cells transfected with negative control siRNA (S2A Fig). Accordingly, immunoflu-
orescence staining showed decreased Wnt5A protein expression in Wnt5A-siRNA transfected
HCAEC compared with negative control siRNA transfected cells (S2B and S2C Fig).
Upon IL-4 treatment, Wnt5A silenced HCAEC showed significantly increased TEER com-
pared with non-transfected HCAEC (Fig 7A). In HCAEC transfected with negative control
siRNA, the response to IL-4 was not altered (Fig 7B).
Since IL-4 upregulated IL-6 in HCAEC in the present study (Fig 3B), and IL-6 has been
reported to increase permeability of HUVEC [37] and bovine vascular endothelial cells
(BVEC) [38], we also investigated whether IL-6 increased permeability of HCAEC monolayers.
Treatment with IL-6 did not alter the TEER of HCAEC monolayer to AC, thereby indicating
that IL-6 does not influence the permeability characteristics of HCAEC (Fig 7C).
IL-4 impairs migration of HCAEC, which can be restored by ROCK
inhibition
Since IL-4 increased the formation of actin stress fibers and caused inter-endothelial gap for-
mation, we investigated whether IL-4 would also affect the motility of HCAEC. In an ECIS sup-
ported wound healing and cell migration assay, IL-4 treated HCAEC exhibited a lower
impedance and required a longer time to heal the wound compared with non-treated cells (Fig
8A). This indicates that IL-4 significantly reduces endothelial cell motility, causing delayed
wound closure.
The present study shows that IL-4 induced phosphorylation of LIMK2 and CFL1 can be
decreased by inhibiting ROCK. Since ROCK regulates cytoskeleton remodeling, cell–cell adhe-
sion and cell motility [33], we investigated whether inhibiting ROCK prevents IL-4 induced
impairment of HCAECmotility. Cells treated with a combination of IL-4 and the ROCK inhib-
itor Y-27632 showed signifcantly higher motility rates and faster wound closure than cells
treated with only IL-4 (Fig 8B).
IL-4 upregulates Wnt5A expression in human macrophages
Since macrophages also play a pivotal role in Th2 inflammation, we asked whether Wnt5A
expression is also upregulated in IL-4 activated human M2 type macrophages. Treatment with
IL-4 significantly upregulated Wnt5A mRNA expression in macrophages (Fig 9).
Discussion
VEC play an important role in maintaining vascular homeostasis. During inflammation, solu-
ble mediators secreted by activated immune cells paracrinically act on VEC and significantly
alter their functions to confer ‘inflamed’ or ‘activated’ phenotypes on them. IL-4 is a potent
Th2 cytokine known to cause activation of VEC and induce endothelial barrier dysfunction
[21]. However, the exact mechanisms responsible for IL-4 dependent endothelial dysfunction
in VEC remained unclear. In the present study, we detected all genes regulated by paracrine IL-
4 signaling in adult VEC by whole human genome microarray based transcriptome profiling
(Fig 1, S1 and S2 Tables).
HCAEC; 2, IL-4 treated negative control siRNA transfected HCAEC; 3, IL-4 treated non-transfected HCAEC.
(C) Black, non-treated; green, IL-6.
doi:10.1371/journal.pone.0156002.g007
IL-4 and Endothelial Barrier Function
PLOS ONE | DOI:10.1371/journal.pone.0156002 May 23, 2016 15 / 22
This is the first study to demonstrate that IL-4 significantly upregulates Wnt5A expression
in adult VEC. A previous study demonstrated that HUVEC treated with a combination of
TNF-α, IL-1 and IL-8 upregulated the expression of Wnt5A mRNA [39]. Wnt5A is a non-
canonical Wnt ligand, recently identified as a pro-inflammatory mediator of macrophage acti-
vation in vascular inflammation [24]. Wnt5A has been demonstrated to enhance the perme-
ability of HUVEC monolayers in a 14C sucrose permeability test [40] and IL-4 caused
morphological changes and induced inter-endothelial gap formation in HUVEC [17]. Further-
more IL-4 has been demonstrated to induce hyperpermeability of HUVEC [21]. Inter-
Fig 8. Automated wound healing assay showing decreasedmotility of IL-4 treated HCAEC.Uniform
confluent monolayers of HCAEC cultured in stabilized and collagen coated ECIS 8W1E cultureware were
treated with IL-4 either alone or in combination with Y-27632. Three hours after treatment, wells were
subjected to an elevated electric field to create a wound. Measurements were started immediately after
wounding. Impedance of HCAECmonolayer was continuously measured in Ohms every 5 min at multiple
frequencies ranging from 62.6 Hz to 64 kHz and plotted with respect to time. Representative figures depict
the impedance of wells after wounding was applied. Figures shown depict the measurements conducted at
4000 Hz and represent four independent experiments. (A) Black, non-treated; Blue, IL-4. (B) Black, control
with Y27632; Green, IL-4 + Y27632.
doi:10.1371/journal.pone.0156002.g008
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endothelial gap formation caused by cytoskeletal rearrangements impairs the barrier functions
of endothelial monolayers and is the principal pathway causing endothelial hyperpermeability
and subsequent edema formation in inflammation [41]. Endothelial hyperpermeability
accounts for increased efflux of plasma through microvessel walls into neighboring tissues,
leading to the formation of protein rich tissue edema. Edema formation resulting from vascular
leakage is an important consequence of allergic inflammation [21] and a most common side
effect of IL-4 therapy in human cancer patients [42]. Addressing a potential role for Wnt5A in
IL-4 induced endothelial cytoskeleton remodeling, GO analyses for the current study point to
Wnt5A as a potential ligand for the ‘Cytoskeleton remodeling_TGF, Wnt and cytoskeletal
remodeling’ pathway (Fig 2). A prominent role for Wnt5A in mediating IL-4 induced cytoskel-
eton remodeling is evident from our observation that IL-4 induced actin stress fiber formation
can be suppressed by blocking Wnt5A signaling (Fig 5). Further proof for the involvement of
Wnt5A is provided by functional experiments demonstrating that the enhanced permeability
of HCAEC monolayers upon IL-4 treatment can be significantly decreased by silencing Wnt5A
expression (Fig 7A). Our findings support the crucial role of Wnt5A in stress fiber formation
and inter-endothelial gap formation, leading to impaired barrier function in IL-4 treated
HCAEC. However, it must be noted that targeting Wnt5A does not completely prevent IL-4
induced stress fiber formation (Fig 5) and endothelial hyperpermeability (Fig 7A). Therefore, it
cannot be excluded that IL-4 contributes to endothelial hyperpermeability also by other yet
unknown mechanisms.
Wnt5A signals mainly through Fzd receptors but can also function through Ryk, a member
of the family of atypical receptor tyrosine-protein kinases (RTKs). Ryk consists of an extracel-
lular Wnt-binding domain, a PDZ binding motif and an intracellular inactive tyrosine kinase
domain. Its Wnt-binding domain is homologous to the extracellular Wnt antagonist, WIF pro-
tein. sFRP1 is another Wnt antagonist that contains a frizzled like cysteine-rich domain (CRD)
homologous to the extracellular Wnt-binding domains of Fzd receptors [35]. The availability
of the receptor, presence of Wnt antagonists and the cellular environment determines which
Fig 9. Wnt5A expression in IL-4 activated humanmacrophages. Fold changes in the expression of
Wnt5A mRNA in IL-4 treated human macrophages. Data were obtained from two independent qRT-PCR
experiments run with duplicate samples using RNA isolated frommacrophages from four different donors and
expressed as the mean ± SEM. *P<0.05 using an unpaired Student’s t- test.
doi:10.1371/journal.pone.0156002.g009
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receptors Wnts engages and the signals that are generated. The involvement of Ryk, but not
Fzd receptors, in IL-4 induced Wnt5A signaling in HCAECs is obvious from our observation
that stress fiber formation was prevented in the presence of WIF1 but not sFRP1 (Fig 5). Others
have demonstrated that Wnt5A/Ryk signaling through Rho-kinase activation inhibits axon
growth in rats [43]. We propose that in HCAEC, Wnt5A signaling through Ryk receptor acti-
vates ROCK that in turn phosphorylates LIMK2. Activated pLIMK2 in turn phosphorylates
CFL1 that is then deactivated, and as a consequence, allows actin fiber polymerization. This
disrupts VE-cadherin assembly in IEJs leading to the formation of inter-endothelial gaps, as we
have observed in the present study (Fig 6B). The involvement of ROCK as a downstream effec-
tor of Wnt5A/Ryk signaling in HCAEC is very well supported by the observations that phos-
phorylation of LIMK2 and CFL1 following IL-4 treatment can be decreased by inhibiting
ROCK (Fig 4). The function of ROCK in IL-4 induced cytoskeleton remodeling is further evi-
dent from the standardized ECIS cell migration assay that shows improved migratory and
wound healing capacity of cells treated with a combination of IL-4 and ROCK inhibitor (Fig
8A and 8B). Phosphorylation of LIMK and CFL at the indicated time points is also in line with
the observations that IL-4 induced LIMK-CFL1 downstream signaling leads to the functional
effects occurring at later time points in this study.
Intriguingly, the present study confirms that IL-6 is upregulated by IL-4 in HCAEC but IL-
6 does not influence TEER in the ECIS based standardized permeability assay (Fig 7C), even
though it increases permeability in HUVEC [37] and BVEC [38]. Further studies are warranted
to confirm that IL-6 is not responsible for increased VEC permeability, or whether this effect of
IL-6 varies between endothelial cells from different vascular beds and thus depends on endo-
thelial heterogeneity.
The whole genome transcriptome analysis of IL-4 treated HCAEC further revealed induction
of vascular endothelial growth factor (VEGF)-A (Table 1, Fig 2). A previous study showed that
IL-4 increased the production of VEGF in unstimulated synovial fibroblasts [44]. VEGF-A acts
as a proangiogenic factor in wound healing. It enhances endothelial cell migration from pre-
existing blood vessels and promotes the recruitment of endothelial progenitor cells (EPCs) from
peripheral circulation [45]. Surprisingly, the present study demonstrates an inhibitory effect of
IL-4 on endothelial cell migration while upregulating VEGF-A. Even though this contradicts the
effects of VEGF in stimulating endothelial cell migration, it could be explained by the observation
that IL-4 downregulates expression of VEGFR-2 (Table 1, Fig 2). VEGFR-2 (also known as
KDR) is a receptor specific for VEGF [45] and downregulation would block autocrine VEGF-A
signaling in endothelial cells. This is a likely feedback mechanism inhibiting angiogenesis. As sol-
uble factors secreted by VEC paracrinically act on other immune cells such as macrophages, it is
also possible that VEGF-A produced by VEC interacts with VEGF receptors expressed on other
immune cells. This view is well supported by previous studies which demonstrated that VEGF-A
acted as a chemoattractant for monocytes expressing VEGF receptor 1 [46–49].
Among the genes highly expressed upon IL-4 treatment of HCAEC (S1 Table), pro-mela-
nin-concentrating hormone (PMCH) has also been described previously as highly induced by
activated Th2 cells [50]. IL-4 triggered expression of hyaluronan synthase 3 (HAS3) may facili-
tate the adhesion and migration of activated immune cells and cancer cells during inflamma-
tory response and cancer metastasis, respectively. Induction of CCL26 by IL-4 has already been
described in VEC and it acts as a chemokine for eosinophils [51].
Conclusions
Our study indicates that Wnt5A is crucially involved in cytoskeleton rearrangement and bar-
rier dysfunction mediated by IL-4 in VEC. We further show that IL-4 induced Wnt5A signals
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downstream through the ROCK–LIMK2–CFL1 pathway and Ryk is a possible receptor for
Wnt5A signaling in VEC. Therapeutic approaches targeting Wnt5A may reduce microvascular
leakage and subsequent edema formation associated with IL-4 driven pathophysiological con-
ditions such as allergic and tumor inflammation. Moreover, we show for the first time that IL-4
induces Wnt5A in human M2 type macrophages, which is different to the Toll-like receptor
(TLR) mediated Wnt5A induction described previously [24]. Together, this establishes Wnt5A
as a component of both classically and alternatively activated macrophages. It can be postulated
that Wnt5A secreted by IL-4 activated vascular endothelial cells and macrophages acts paracri-
nically on vascular smooth muscle cells. Further studies delineating the specific role of Wnt5A
in alternatively activated macrophages and vascular smooth muscle cells would provide novel
insights into the inflammatory responses in diseases associated with Th2 activity.
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